Viewing Study NCT04465734


Ignite Creation Date: 2025-12-25 @ 2:30 AM
Ignite Modification Date: 2026-03-01 @ 1:45 PM
Study NCT ID: NCT04465734
Status: WITHDRAWN
Last Update Posted: 2022-05-05
First Post: 2020-07-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Clinical Study to Compare the Efficacy and Safety of HLX10 in Combination With HLX04 Versus Sorafenib as the First-line Treatment in Patients With Locally Advanced or Metastatic HCC
Sponsor: Shanghai Henlius Biotech
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatocellular Carcinoma (HCC) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Locally Advanced or Metastatic View
None Hepatocellular Carcinoma (HCC) View